We are live on ! Find out more
CSBR icon

Champions Oncology

44 hedge funds and large institutions have $66.1M invested in Champions Oncology in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

325% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 4

38% more capital invested

Capital invested by funds: $47.8M → $66.1M (+$18.3M)

38% more funds holding

Funds holding: 3244 (+12)

3.76% more ownership

Funds ownership: 54.4%58.16% (+3.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
44
Holders Change
+12
Holders Change %
+37.5%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
17
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$125K +$92.2K +10,820 +480%
N
27
Nuveen
North Carolina
$121K +$108K +12,642 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$104K +$92.7K +10,879 New
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$103K +$92.1K +10,800 New
Bank of America
30
Bank of America
North Carolina
$59K +$52.3K +6,140 New
TRCT
31
Tower Research Capital (TRC)
New York
$50K +$43.4K +5,097 +2,655%
AIG
32
American International Group
New York
$42K +$37.6K +4,413 New
Barclays
33
Barclays
United Kingdom
$38K +$33.9K +3,981 New
Wells Fargo
34
Wells Fargo
California
$35K +$31.2K +3,660 +9,892%
Deutsche Bank
35
Deutsche Bank
Germany
$32K +$28.3K +3,321 New
UBS Group
36
UBS Group
Switzerland
$31K +$27.7K +3,252 New
SO
37
STRS Ohio
Ohio
$18K +$16.2K +1,900 New
Legal & General Group
38
Legal & General Group
United Kingdom
$11K +$10.1K +1,181 New
Osaic Holdings
39
Osaic Holdings
Arizona
$10K +$8.63K +1,013 +8,442%
Citigroup
40
Citigroup
New York
$9K +$7.82K +917 New
AIP
41
Ameritas Investment Partners
Nebraska
$6K +$5.43K +637 New
PAM
42
Panagora Asset Management
Massachusetts
$4K
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$2.58K +$2.3K +270 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$1K -$68 -8 -7%
CPA
45
Cowen Prime Advisors
New York
-$2.22M -299,400 Closed
AIM
46
Alambic Investment Management
California
-$86K -11,676 Closed
VIMU
47
Veritas Investment Management (UK)
United Kingdom
-$15K -2,083 Closed
Victory Capital Management
48
Victory Capital Management
Texas
-$16K -2,054 Closed

CSBR Hedge Fund Activity: Q2 2020 in Review

44 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2020, worth a combined $66.1M — up 38% from $47.8M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CSBR positions and 4 closed out — a net gain of 13 holders — while 17 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $2.45M. The largest seller was Cowen Prime Advisors, exiting entirely with an estimated $2.22M sold.

  • 44 institutional investors held Champions Oncology (CSBR) as of Q2 2020, up from 32 in Q1 2020.
  • Funds reported $66.1M of Champions Oncology stock for Q2 2020, up 38% quarter-over-quarter.
  • 17 funds opened new Champions Oncology positions in Q2 2020 and 4 closed out, a net change of +13 holders.
  • The largest Champions Oncology buyer in Q2 2020 was BlackRock, an estimated $2.45M added.
  • The largest Champions Oncology seller in Q2 2020 was Cowen Prime Advisors, an estimated $2.22M sold.

Based on aggregated 13F filings for Q2 2020.